SUCNR1 and cancer: Although several SUCNR1 receptor inhibitors have been synthesized to date [82], with compelling evidence that proves their efficacy in blocking tumor and metastatic progression in various cancer cell types [128,129], their clinical implication has been limited due to the serious side effects caused by SUCNR1 inhibition.